StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Nothing but Aristotle revenue and big partnerships

<< Previous

Bullboard Posts

Next >>

Comment by Liked2Thinkon Jun 02, 2021 10:58am

62 Views

Post# 33310553

RE:RE:Nothing but Aristotle revenue and big partnerships

If they do what you brought up as a possibility then yeah thats some serious BS.

That would also mean they value the health clinic way too much if you ask me.

Although considering they are dead in the water without this additional company when it comes to Aristotle maybe it is worth it.

<< Previous

Bullboard Posts

Next >>

A PGM mining stock with value written all over it